Back
Biomarin Pharmaceutical Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
57
BMRN
Biomarin Pharmaceutical
Last Price:
62.07
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Biomarin Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.33 | Sell |
| 20-day SMA: | 66.31 | Sell |
| 50-day SMA: | 69.39 | Sell |
| 200-day SMA: | 81.31 | Sell |
| 8-day EMA: | 63.89 | Sell |
| 20-day EMA: | 65.94 | Sell |
| 50-day EMA: | 70.23 | Sell |
| 200-day EMA: | 79.7 | Sell |
Biomarin Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.16 | Sell |
| Relative Strength Index (14 RSI): | 27.46 | Sell |
| Chaikin Money Flow: | 863717 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.41 - 69.77) | Sell |
| Bollinger Bands (100): | (68.48 - 87.38) | Sell |
Biomarin Pharmaceutical Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Biomarin Pharmaceutical Stock
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 62.56 while BMRN 8-day simple moving average is 64.33, which is a Sell signal.
- The stock price of BMRN is 62.56 while Biomarin Pharmaceutical 20-day SMA is 66.31, which makes it a Sell.
- Biomarin Pharmaceutical 50-day simple moving average is 69.39 while BMRN share price is 62.56, making it a Sell technically.
- BMRN stock price is 62.56 and Biomarin Pharmaceutical 200-day simple moving average is 81.31, creating a Sell signal.
BMRN Technical Analysis vs Fundamental Analysis
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy or a Sell?
-
Biomarin Pharmaceutical stock is rated a Buy
The current Biomarin Pharmaceutical [BMRN] share price is $62.56. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Biomarin Pharmaceutical Stock Info
Market Cap:
11.92B
Price in USD:
62.56
Share Volume:
1.16M
Biomarin Pharmaceutical 52-Week Range
52-Week High:
99.56
52-Week Low:
61.40
Buy
57
Biomarin Pharmaceutical (BMRN)
is a Buy
Biomarin Pharmaceutical Share Price Forecast
-
What is the Biomarin Pharmaceutical stock price today?
The Biomarin Pharmaceutical stock price is 62.56 USD today. -
Will BMRN stock go up or go down?
Biomarin Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Biomarin Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Biomarin Pharmaceutical is not overvalued.
Is Biomarin Pharmaceutical Stock a Buy?
- Biomarin Pharmaceutical share price is 62.56 while BMRN 8-day exponential moving average is 63.89, which is a Sell signal.
- The stock price of BMRN is 62.56 while Biomarin Pharmaceutical 20-day EMA is 65.94, which makes it a Sell.
- Biomarin Pharmaceutical 50-day exponential moving average is 70.23 while BMRN share price is 62.56, making it a Sell technically.
- BMRN stock price is 62.56 and Biomarin Pharmaceutical 200-day simple moving average is 79.70, creating a Sell signal.
Fundamental Analysis of Biomarin Pharmaceutical
Is Biomarin Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.
Technical Analysis of Biomarin Pharmaceutical
Should I short Biomarin Pharmaceutical stock?
- BMRN Moving Average Covergence Divergence (MACD) indicator is -2.16, suggesting Biomarin Pharmaceutical is a Sell
- Biomarin Pharmaceutical Relative Strength Index (RSI) is 27.46, which suggest Biomarin Pharmaceutical is oversold
- The Bollinger Bands (25) for Biomarin Pharmaceutical is (64.41 - 69.77), which suggest Biomarin Pharmaceutical is a Sell
- The Bollinger Bands (100) for Biomarin Pharmaceutical is (68.48 - 87.38), which suggest Biomarin Pharmaceutical is a Sell
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.